RUA Life Sciences plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RUA.L research report →
Companyrualifesciences.com
RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices, as well as reaction injection molding technology for use in high-precision medical device components. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves.
- CEO
- William Donald Brown
- IPO
- 1997
- Employees
- 40
- HQ
- Irvine, GB
Price Chart
Valuation
- Market Cap
- $13.61M
- P/E
- -93.62
- P/S
- 3.05
- P/B
- 1.90
- EV/EBITDA
- -30.55
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 68.56%
- Op Margin
- -18.54%
- Net Margin
- -3.26%
- ROE
- -2.03%
- ROIC
- -9.97%
Growth & Income
- Revenue
- $4.46M · 8.42%
- Net Income
- $-145,334 · -14633.40%
- EPS
- $-0.00 · 0.00%
- Op Income
- $-826,670
- FCF YoY
- -6.05%
Performance & Tape
- 52W High
- $26.80
- 52W Low
- $10.42
- 50D MA
- $17.15
- 200D MA
- $13.70
- Beta
- 0.97
- Avg Volume
- 276.86K
Get TickerSpark's AI analysis on RUA.L
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our RUA.L Coverage
We haven't published any research on RUA.L yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RUA.L Report →